دورية أكاديمية
Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders
| العنوان: | Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders |
|---|---|
| المؤلفون: | Jeremy Chung Bo Chiang, Ria Arnold, Roshan Dhanapalaratnam, Maria Markoulli, Arun V. Krishnan |
| المصدر: | Pharmaceuticals, Vol 15, Iss 5, p 607 (2022) |
| بيانات النشر: | MDPI AG, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Medicine LCC:Pharmacy and materia medica |
| مصطلحات موضوعية: | cancer, chemotherapy, chronic kidney failure, diabetes mellitus, immune system diseases, neuropathy, Medicine, Pharmacy and materia medica, RS1-441 |
| الوصف: | Peripheral nerve disorders are caused by a range of different aetiologies. The range of causes include metabolic conditions such as diabetes, obesity and chronic kidney disease. Diabetic neuropathy may be associated with severe weakness and the loss of sensation, leading to gangrene and amputation in advanced cases. Recent studies have indicated a high prevalence of neuropathy in patients with chronic kidney disease, also known as uraemic neuropathy. Immune-mediated neuropathies including Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy may cause significant physical disability. As survival rates continue to improve in cancer, the prevalence of treatment complications, such as chemotherapy-induced peripheral neuropathy, has also increased in treated patients and survivors. Notably, peripheral neuropathy associated with these conditions may be chronic and long-lasting, drastically affecting the quality of life of affected individuals, and leading to a large socioeconomic burden. This review article explores some of the major emerging clinical and experimental therapeutic agents that have been investigated for the treatment of peripheral neuropathy due to metabolic, toxic and immune aetiologies. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1424-8247 |
| العلاقة: | https://www.mdpi.com/1424-8247/15/5/607Test; https://doaj.org/toc/1424-8247Test |
| DOI: | 10.3390/ph15050607 |
| الوصول الحر: | https://doaj.org/article/47409c803d3d4ccdba976c38463ef849Test |
| رقم الانضمام: | edsdoj.47409c803d3d4ccdba976c38463ef849 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | ResultId |
1 |
|---|---|
| Header |
edsdoj Directory of Open Access Journals edsdoj.47409c803d3d4ccdba976c38463ef849 935 3 Academic Journal academicJournal 934.699645996094 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.47409c803d3d4ccdba976c38463ef849&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doaj.org/article/47409c803d3d4ccdba976c38463ef849 [Name] => EDS - DOAJ [Category] => fullText [Text] => View record in DOAJ [MouseOverText] => View record in DOAJ ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsdoj&genre=article&issn=14248247&ISBN=&volume=15&issue=5&date=20220501&spage=607&pages=607-607&title=Pharmaceuticals&atitle=Current%20and%20Emerging%20Pharmacotherapeutic%20Interventions%20for%20the%20Treatment%20of%20Peripheral%20Nerve%20Disorders&id=DOI:10.3390/ph15050607 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Jeremy+Chung+Bo+Chiang%22">Jeremy Chung Bo Chiang</searchLink><br /><searchLink fieldCode="AR" term="%22Ria+Arnold%22">Ria Arnold</searchLink><br /><searchLink fieldCode="AR" term="%22Roshan+Dhanapalaratnam%22">Roshan Dhanapalaratnam</searchLink><br /><searchLink fieldCode="AR" term="%22Maria+Markoulli%22">Maria Markoulli</searchLink><br /><searchLink fieldCode="AR" term="%22Arun+V%2E+Krishnan%22">Arun V. Krishnan</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Pharmaceuticals, Vol 15, Iss 5, p 607 (2022) ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => MDPI AG, 2022. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2022 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => LCC:Medicine<br />LCC:Pharmacy and materia medica ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22cancer%22">cancer</searchLink><br /><searchLink fieldCode="DE" term="%22chemotherapy%22">chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22chronic+kidney+failure%22">chronic kidney failure</searchLink><br /><searchLink fieldCode="DE" term="%22diabetes+mellitus%22">diabetes mellitus</searchLink><br /><searchLink fieldCode="DE" term="%22immune+system+diseases%22">immune system diseases</searchLink><br /><searchLink fieldCode="DE" term="%22neuropathy%22">neuropathy</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacy+and+materia+medica%22">Pharmacy and materia medica</searchLink><br /><searchLink fieldCode="DE" term="%22RS1-441%22">RS1-441</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Peripheral nerve disorders are caused by a range of different aetiologies. The range of causes include metabolic conditions such as diabetes, obesity and chronic kidney disease. Diabetic neuropathy may be associated with severe weakness and the loss of sensation, leading to gangrene and amputation in advanced cases. Recent studies have indicated a high prevalence of neuropathy in patients with chronic kidney disease, also known as uraemic neuropathy. Immune-mediated neuropathies including Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy may cause significant physical disability. As survival rates continue to improve in cancer, the prevalence of treatment complications, such as chemotherapy-induced peripheral neuropathy, has also increased in treated patients and survivors. Notably, peripheral neuropathy associated with these conditions may be chronic and long-lasting, drastically affecting the quality of life of affected individuals, and leading to a large socioeconomic burden. This review article explores some of the major emerging clinical and experimental therapeutic agents that have been investigated for the treatment of peripheral neuropathy due to metabolic, toxic and immune aetiologies. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => electronic resource ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1424-8247 ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://www.mdpi.com/1424-8247/15/5/607; https://doaj.org/toc/1424-8247 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.3390/ph15050607 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://doaj.org/article/47409c803d3d4ccdba976c38463ef849" linkWindow="_blank">https://doaj.org/article/47409c803d3d4ccdba976c38463ef849</link> ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsdoj.47409c803d3d4ccdba976c38463ef849 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.3390/ph15050607
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 1
[StartPage] => 607
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => cancer
[Type] => general
)
[1] => Array
(
[SubjectFull] => chemotherapy
[Type] => general
)
[2] => Array
(
[SubjectFull] => chronic kidney failure
[Type] => general
)
[3] => Array
(
[SubjectFull] => diabetes mellitus
[Type] => general
)
[4] => Array
(
[SubjectFull] => immune system diseases
[Type] => general
)
[5] => Array
(
[SubjectFull] => neuropathy
[Type] => general
)
[6] => Array
(
[SubjectFull] => Medicine
[Type] => general
)
[7] => Array
(
[SubjectFull] => Pharmacy and materia medica
[Type] => general
)
[8] => Array
(
[SubjectFull] => RS1-441
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jeremy Chung Bo Chiang
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ria Arnold
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Roshan Dhanapalaratnam
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Maria Markoulli
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Arun V. Krishnan
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 05
[Type] => published
[Y] => 2022
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 14248247
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 15
)
[1] => Array
(
[Type] => issue
[Value] => 5
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Pharmaceuticals
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |